Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Pili prove pertinent to enterococcal endocarditis
Jonathan M. Budzik, Olaf Schneewind
Jonathan M. Budzik, Olaf Schneewind
Published October 2, 2006
Citation Information: J Clin Invest. 2006;116(10):2582-2584. https://doi.org/10.1172/JCI30088.
View: Text | PDF
Commentary

Pili prove pertinent to enterococcal endocarditis

  • Text
  • PDF
Abstract

Enterococcus faecalis is an important agent of endocarditis and urinary tract infections, which occur frequently in hospitals. Antimicrobial therapy is complicated by the emergence of drug-resistant strains, which contribute significantly to mortality associated with E. faecalis infection. In this issue of the JCI, Nallapareddy and colleagues report that E. faecalis produces pili on its surface and that these proteinaceous fibers are used for bacterial adherence to host tissues and for the establishment of biofilms and endocarditis (see the related article beginning on page 2799). This information may enable new vaccine strategies for the prevention of E. faecalis infections.

Authors

Jonathan M. Budzik, Olaf Schneewind

×

Figure 1

Role for pili in the establishment of E. faecalis infection.

Options: View larger image (or click on image) Download as PowerPoint
Role for pili in the establishment of E. faecalis infection.
           ...
Enterococci may use pili (surface fibrils) for microbial attachment to host tissues (i). Surface proteins (e.g., AS, Esp, and Ace) are involved in establishing tight bacterial adherence to host cells (ii). Enterococcal aggregation induces biofilm formation (iii) and elaboration of exopolysaccharide matrix (blue surface layer). Quorum-sensing–controlled expression of protease and cytolysin mediate host cell death and spread of infection (iv). Schematic modified with permission from ASM Press (1).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts